OrbiMed Israel BioFund GP Limited Partnership's Net Worth
$0
Estimate Recalculated Nov 1, 2024 06:37AM EST
Who is OrbiMed Israel BioFund GP Limited Partnership?
OrbiMed Israel BioFund GP Limited Partnership does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Adicet Bio, Inc., BiomX Inc., Chemomab Therapeutics Ltd., INNOVATE BIOPHARMACEUTICALS, INC., and Novus Therapeutics, Inc..
SEC CIK
OrbiMed Israel BioFund GP Limited Partnership's CIK is 0001569821
Past Insider Trading and Trends
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Adicet Bio, Inc. (ACET) Snapshot price: $1.56
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +47.01% | 3.13M |
$2.40 | $7,500,000.00 | 9.77M |
Jan 25
| |||
Form 4
| +12.10% | 875K |
$2.09 | $1,828,750.00 | 8.11M |
Jun 27
| |||
Form 4
| +765.30% | 214.28K |
$14.00 | $2,999,990.00 | 242.28K |
Dec 10
| |||
Form 4
| +10.25% | 524.35K |
$13.00 | $6,816,537.00 | 5.64M |
Feb 12
| |||
Form 4
|
∞
| 6.02M |
—
|
—
| 6.02M |
Sep 15 - Sep 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
BiomX Inc. (PHGE) Snapshot price: $1.2094
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +204.89% | 9.26M |
$0.31 | $2,255,139.62 | 13.77M |
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 15
| |||
Form 4
| +12.37% | 348K |
$0.25 | $85,260.00 | 3.16M |
Feb 27
| |||
Form 4
| +21.61% | 500K |
—
|
—
| 2.81M |
Jul 28
| |||
Form 4
| +0.17% | 4K |
$8.90 | $35,615.00 | 2.31M |
Dec 18 - Dec 19
| |||
Form 4
| +0.38% | 8.8K |
$8.85 | $77,918.00 | 2.31M |
Dec 10 - Dec 11
| |||
Form 4
| +0.45% | 10.2K |
$8.40 | $85,646.00 | 2.3M |
Dec 5 - Dec 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Chemomab Therapeutics Ltd. (CMMB) Snapshot price: $1.95
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -13.07% | -336.90K |
$3.58 | -$1,207,759.08 | 2.24M |
Jan 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +12.58% | 288.17K |
$17.35 | $4,999,749.50 | 2.58M |
Mar 16
| |||
| No matching records found | |||||||||
INNOVATE BIOPHARMACEUTICALS, INC. (NMTRQ) Snapshot price: $0.000001
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -66.69% | -17.15M |
$1.22 | -$20,932,965.86 | 8.57M |
Jun 23 - Jun 25
| |||
Form 4
| +0.06% | 31.94K |
$0.66 | $20,836.39 | 51.48M |
May 11
| |||
Form 4/A
|
∞
| 18.93M |
—
|
—
| 18.93M |
Apr 30 - May 4
| |||
Form 4
| +8.18% | 1.94M |
—
|
—
| 25.72M |
Oct 30
| |||
Form 4
| +39.95% | 6.79M |
—
|
—
| 23.77M |
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Novus Therapeutics, Inc. (ELDN) Snapshot price: $2.664
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -58.35% | -103.20K |
$21.60 | -$2,229,120.00 | 73.65K |
Dec 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 14
| |||
Form 4
| +25.47% | 646.2K |
$3.10 | $2,003,232.40 | 3.18M |
May 2
| |||
Form 4
|
∞
| 2.54M |
—
|
—
| 2.54M |
May 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||